Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren’s syndrome

Podobne zapisy

• Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren’s Syndrome
  od: Nakamura, Hideki, i wsp.
  Wydane: (2018)
• Role of Viral Infections in the Pathogenesis of Sjögren’s Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1
  od: Nakamura, Hideki, i wsp.
  Wydane: (2020)
• Combined classification system based on ACR/EULAR and ultrasonographic scores for improving the diagnosis of Sjögren's syndrome
  od: Takagi, Yukinori, i wsp.
  Wydane: (2018)
• Role of the Innate Immunity Signaling Pathway in the Pathogenesis of Sjögren’s Syndrome
  od: Shimizu, Toshimasa, i wsp.
  Wydane: (2021)
• Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy
  od: Fukui, Shoichi, i wsp.
  Wydane: (2017)